Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025
Kestra Medical Technologies (Nasdaq: KMTS) announced its participation in Heart Rhythm 2025, the annual Heart Rhythm Society meeting, scheduled for April 24-27 at the San Diego Convention Center. This marks the company's first major industry showcase following its recent IPO.
The company will showcase its ASSURE® system, a wearable medical device that combines defibrillation therapy with diagnostic and patient support capabilities. The exhibition will feature an immersive in-booth experience demonstrating the system's role in protecting patients at risk of sudden cardiac arrest.
During the event, Kestra will present new real-world clinical data about the ASSURE system's impact and continue its sponsorship of the Women in EP Luncheon for the fourth consecutive year.
Kestra Medical Technologies (Nasdaq: KMTS) ha annunciato la sua partecipazione a Heart Rhythm 2025, l'annuale congresso della Heart Rhythm Society, previsto dal 24 al 27 aprile presso il San Diego Convention Center. Questo rappresenta la prima grande vetrina del settore per l'azienda dopo la recente IPO.
L'azienda presenterà il suo sistema ASSURE®, un dispositivo medico indossabile che unisce terapia di defibrillazione a capacità diagnostiche e di supporto al paziente. L'esposizione offrirà un'esperienza immersiva all'interno dello stand, dimostrando il ruolo del sistema nella protezione dei pazienti a rischio di arresto cardiaco improvviso.
Durante l'evento, Kestra presenterà nuovi dati clinici reali sull'impatto del sistema ASSURE e proseguirà la sponsorizzazione del Women in EP Luncheon per il quarto anno consecutivo.
Kestra Medical Technologies (Nasdaq: KMTS) anunció su participación en Heart Rhythm 2025, la reunión anual de la Heart Rhythm Society, programada del 24 al 27 de abril en el San Diego Convention Center. Esta será la primera gran presentación de la empresa tras su reciente salida a bolsa.
La compañía mostrará su sistema ASSURE®, un dispositivo médico portátil que combina terapia de desfibrilación con capacidades diagnósticas y de apoyo al paciente. La exhibición contará con una experiencia inmersiva en el stand que demostrará el papel del sistema en la protección de pacientes en riesgo de paro cardíaco súbito.
Durante el evento, Kestra presentará nuevos datos clínicos del mundo real sobre el impacto del sistema ASSURE y continuará patrocinando el Women in EP Luncheon por cuarto año consecutivo.
Kestra Medical Technologies (나스닥: KMTS)는 4월 24일부터 27일까지 샌디에이고 컨벤션 센터에서 열리는 연례 Heart Rhythm Society 회의인 Heart Rhythm 2025에 참여한다고 발표했습니다. 이는 최근 IPO 이후 회사의 첫 주요 산업 전시입니다.
회사는 제세동 치료와 진단 및 환자 지원 기능을 결합한 웨어러블 의료기기인 ASSURE® 시스템을 선보일 예정입니다. 전시 부스에서는 돌연 심장 정지 위험이 있는 환자를 보호하는 시스템의 역할을 체험할 수 있는 몰입형 경험이 제공됩니다.
행사 기간 동안 Kestra는 ASSURE 시스템의 영향에 대한 새로운 실제 임상 데이터를 발표하고, 4년 연속으로 Women in EP Luncheon 후원을 계속할 예정입니다.
Kestra Medical Technologies (Nasdaq : KMTS) a annoncé sa participation à Heart Rhythm 2025, la réunion annuelle de la Heart Rhythm Society, prévue du 24 au 27 avril au San Diego Convention Center. Il s'agit de la première grande présentation de l'entreprise depuis son introduction en bourse récente.
L'entreprise présentera son système ASSURE®, un dispositif médical portable qui combine thérapie de défibrillation, capacités diagnostiques et soutien aux patients. L'exposition proposera une expérience immersive au sein du stand, démontrant le rôle du système dans la protection des patients à risque d'arrêt cardiaque soudain.
Lors de l'événement, Kestra présentera de nouvelles données cliniques issues du monde réel sur l'impact du système ASSURE et poursuivra son parrainage du Women in EP Luncheon pour la quatrième année consécutive.
Kestra Medical Technologies (Nasdaq: KMTS) gab seine Teilnahme an Heart Rhythm 2025 bekannt, dem jährlichen Treffen der Heart Rhythm Society, das vom 24. bis 27. April im San Diego Convention Center stattfindet. Dies ist die erste große Branchenpräsentation des Unternehmens nach dem kürzlichen Börsengang.
Das Unternehmen wird sein ASSURE®-System vorstellen, ein tragbares medizinisches Gerät, das Defibrillationstherapie mit diagnostischen und patientenunterstützenden Funktionen kombiniert. Die Ausstellung bietet eine immersive Erfahrung am Stand, die die Rolle des Systems beim Schutz von Patienten mit Risiko für plötzlichen Herzstillstand demonstriert.
Während der Veranstaltung wird Kestra neue klinische Realwelt-Daten zur Wirkung des ASSURE-Systems präsentieren und seine Unterstützung des Women in EP Luncheon zum vierten Mal in Folge fortsetzen.
- First major industry showcase post-IPO indicates growing market presence
- Presentation of new real-world clinical data demonstrates product effectiveness
- None.
Company to spotlight ASSURE WCD performance and expanded clinical applications
KIRKLAND, Wash., April 23, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, announced today it will exhibit at Heart Rhythm 2025, the annual meeting of the Heart Rhythm Society (HRS), taking place April 24-27 at the San Diego Convention Center. This marks Kestra’s first major industry showcase following its successful IPO earlier this year.
Kestra will debut an immersive in-booth experience designed to bring the ASSURE® system to life—demonstrating how this innovative technology is redefining protection for patients at risk of sudden cardiac arrest. By combining lifesaving defibrillation therapy with intuitive, intelligent, and connected diagnostic and patient support capabilities, the ASSURE system is a key part of a broader vision for a holistic cardiac care ecosystem that supports patients and providers across the recovery journey.
“Our presence at Heart Rhythm 2025 comes at a pivotal time for Kestra,” said Brian Webster, President and Chief Executive Officer of Kestra. “Following our IPO, we’re moving forward with increasing momentum—and this year’s HRS meeting is an opportunity to demonstrate how the ASSURE system goes beyond protection to offer a smarter, more connected recovery experience for both patients and care teams.”
In addition to exhibiting, Kestra will also present new real-world clinical data highlighting the impact of the ASSURE system. Kestra is also proud to sponsor the Women in EP Luncheon for the fourth consecutive year—underscoring its ongoing commitment to leadership, innovation, and equity in cardiovascular care.
About Kestra
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, please visit www.kestramedical.com.
Media contact
Rhiannon Pickus
rhiannon.pickus@kestramedical.com
Investor contact
Neil Bhalodkar
neil.bhalodkar@kestramedical.com
FAQ
What will Kestra Medical Technologies (KMTS) showcase at Heart Rhythm 2025?
When and where is Kestra Medical Technologies (KMTS) presenting at Heart Rhythm 2025?
What new data will KMTS present at Heart Rhythm 2025?
How is KMTS supporting diversity in cardiovascular care at Heart Rhythm 2025?
